Absence of myeloid Klf4 reduces prostate cancer growth with pro-atherosclerotic activation of tumor myeloid cells and infiltration of CD8 T cells

• David J. Barakat,

  Roles Conceptualization, Formal analysis, Investigation, Writing – review & editing

  Affiliation Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Rahul Suresh,

  Roles Investigation, Writing – review & editing

  Affiliation Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Theresa Barberi,

  Roles Investigation, Writing – review & editing

  Affiliation Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Kenneth J. Pienta,

  Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing

  Affiliations Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Brian W. Simons,

  Roles Conceptualization, Investigation, Methodology, Supervision, Writing – review & editing

  Affiliation Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Alan D. Friedman

  Roles Conceptualization, Funding acquisition, Investigation, Supervision, Writing – original draft

  * E-mail: afriedm2@jhmi.edu

  Affiliation Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  http://orcid.org/0000-0002-5615-7061

  ⨯